Company Filing History:
Years Active: 2023
Title: Innovations in Gene Therapy by Yingwen Li
Introduction
Yingwen Li is a prominent inventor based in Suzhou, China, known for his contributions to the field of gene therapy. With a focus on lipid compounds and their applications in pharmaceutical preparations, he has made significant strides in enhancing the delivery efficiency of nucleic acid drugs. His innovative work has led to the development of two notable patents.
Latest Patents
Yingwen Li's latest patents include a series of lipid compounds and lipid vectors, specifically designed for nucleic acid lipid nanoparticle compositions. These inventions aim to improve the encapsulation efficiency of nucleic acid drugs and enhance their in-vivo delivery. The compounds he developed exhibit pH responsiveness, allowing for targeted delivery to specific organs, which presents a promising market application prospect.
Career Highlights
Yingwen Li is currently associated with Purecodon (Hong Kong) Biopharma Ltd., where he continues to advance his research in gene therapy. His work is characterized by a commitment to developing innovative solutions that address critical challenges in drug delivery systems.
Collaborations
Throughout his career, Yingwen Li has collaborated with notable colleagues, including Ke Huang and Yuping Liu. These partnerships have fostered a collaborative environment that enhances the research and development of gene therapy technologies.
Conclusion
Yingwen Li's contributions to the field of gene therapy through his innovative patents and collaborative efforts position him as a key figure in advancing pharmaceutical preparations. His work holds great potential for improving the efficacy of nucleic acid drug delivery systems.